New name 2015 - Anglonordic Life Science Conference XII
The Anglonordic Medtech Conference will merge with the Anglonordic Biotech Conference and the new name, starting 2015, is Anglonordic Life Science Conference XII. The conference will continue with its successful concept and keep its "by invitation only" policy. The select audience is restricted to decision makers representing drug discovery and medtech companies from the Anglo-Nordic regions and international pharmaceutical and investment firms. Service suppliers can only attend as sponsors and exhibitors. Further information will follow soon.
CLICK HERE to watch the latest PharmaTelevision News Review and get the conference background from the conference founder Mattias Johansson.
Be a conference sponsor!
The conference invites you to be part of this successful event. Through an understanding of your corporate objectives, we can develop a package of benefits tailored to meet your individual needs and budget.
Click here to download the Sponsor Catalogue 2014.
The Reception 2014Conference delegates are invited to the Reception at the Norwegian Ambassador's Residence in London, held in the evening of the 9th of April.
Example of registered companies: Cell Therapy Catapult, Alexion, MSD, GE Healthcare, Millipore, AstraZeneca, Merck Serono Ventures, Bristol-Myers Squibb, Lundbeckfond Ventures, MVM Life Science, Wellington Partners, Imperial Innovation, Medivir, Teva, Index Ventures, Entrepreneurs Fund, Verdant Venture, Debiopharm, NeoMed.